28
Participants
Start Date
June 30, 2008
Primary Completion Date
November 30, 2009
Study Completion Date
November 30, 2009
RAD001
Dose levels will change: Taken orally either every other day for the first three weeks of each cycle or taken every day for the first three weeks of each cycle.
lenalidomide
Dose level will vary: taken orally 30-60 minutes after taking RAD001 every day for the first three weeks of each cycle.
Memorial Sloan-Kettering Cancer Center, New York
Mayo Clinic, Rochester
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Medical College of Wisconsin, Milwaukee
Collaborators (1)
Dana-Farber Cancer Institute
OTHER
Brigham and Women's Hospital
OTHER
Mayo Clinic
OTHER
Memorial Sloan Kettering Cancer Center
OTHER
Medical College of Wisconsin
OTHER
Massachusetts General Hospital
OTHER